Format

Send to

Choose Destination
See comment in PubMed Commons below
Nihon Rinsho. 2007 Nov;65(11):1985-90.

[Poorly differentiated carcinoma of the thyroid].

[Article in Japanese]

Author information

  • 1Department of Surgery, Kuma Hospital.

Abstract

Poorly differentiated carcinoma is adopted as an independent entity in World Health Organization (WHO) and in General Rules for the Description of Thyroid Cancer by The Japanese Society of Thyroid Surgery (JSTS), but their definitions are significantly different. In this study, we investigated the prevalence and clinical significance of poorly differentiated carcinoma by WHO classification (poorly differentiated carcinoma [WHO]) and that in JSTS (poorly differentiated carcinoma [Sakamoto]), and tall cell variant in papillary carcinoma. In our series of 1,707 patients, 186 (10.9%), 15 (0.9%) and 62 (3.6%) were diagnosed as poorly differentiated carcinoma (Sakamoto), poorly differentiated carcinoma (WHO) and tall cell variant, respectively. Poorly differentiated carcinoma (WHO) and tall cell variant independently affected cause-specific survival (CSS) of patients, but poor differentiation (Sakamoto) did not. Therefore, it is suggested that poorly differentiated carcinoma (Sakamoto) predicted the likeliness of carcinoma recurrence, it is inappropriate to separate it as an independent histology.

PMID:
18018559
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk